Detalhe da pesquisa
1.
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356450
2.
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.
J Transl Med
; 21(1): 837, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990219
3.
Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia.
Blood
; 135(12): 921-933, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971569
4.
Total body irradiation as part of conditioning regimens in childhood leukemia-long-term outcome, toxicity, and secondary malignancies.
Strahlenther Onkol
; 198(1): 33-38, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282476
5.
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia.
Haematologica
; 107(1): 49-57, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33299233
6.
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 69(8): e29715, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482538
7.
Blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Eur J Haematol
; 106(4): 473-483, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33320384
8.
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 325(9): 843-854, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651091
9.
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
Proc Natl Acad Sci U S A
; 114(20): E4030-E4039, 2017 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28461505
10.
Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Br J Haematol
; 185(2): 266-283, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714092
11.
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia.
Blood
; 129(11): e26-e37, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122742
12.
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.
Haematologica
; 104(9): 1812-1821, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30705097
13.
High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 66(8): e27780, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31034759
14.
Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial.
Br J Haematol
; 183(1): 104-109, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028016
15.
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial.
Br J Haematol
; 180(1): 82-89, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29193007
16.
An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia.
Br J Haematol
; 181(4): 523-527, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29676440
17.
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
Blood
; 127(17): 2101-12, 2016 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888258
18.
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
Br J Haematol
; 179(2): 272-283, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771662
19.
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid.
Pediatr Blood Cancer
; 64(8)2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28111878
20.
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.
Hum Mol Genet
; 23(3): 590-601, 2014 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24045615